Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:methylglucosides'
(id=6731446 ; fe=en:methylglucosides ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=1861 creation date=2017-06-21 touchdate=2025-07-25 13:11:41.000)
≈ 56 relations sortantes

  1. en:methylglucosides -- r_associated #0: 43 / 1 -> en:aspects of radiation effects
    n1=en:methylglucosides | n2=en:aspects of radiation effects | rel=r_associated | relid=0 | w=43
  2. en:methylglucosides -- r_associated #0: 40 / 0.93 -> en:methyl 4-thio-alpha-maltoside
    n1=en:methylglucosides | n2=en:methyl 4-thio-alpha-maltoside | rel=r_associated | relid=0 | w=40
  3. en:methylglucosides -- r_associated #0: 39 / 0.907 -> en:iridoid glucosides
    n1=en:methylglucosides | n2=en:iridoid glucosides | rel=r_associated | relid=0 | w=39
  4. en:methylglucosides -- r_associated #0: 35 / 0.814 -> en:genetic aspects
    n1=en:methylglucosides | n2=en:genetic aspects | rel=r_associated | relid=0 | w=35
  5. en:methylglucosides -- r_associated #0: 35 / 0.814 -> en:methyl 2,3,4,6-tetra-o-methylglucopyranoside
    n1=en:methylglucosides | n2=en:methyl 2,3,4,6-tetra-o-methylglucopyranoside | rel=r_associated | relid=0 | w=35
  6. en:methylglucosides -- r_associated #0: 35 / 0.814 -> en:pharmacokinetic aspects
    n1=en:methylglucosides | n2=en:pharmacokinetic aspects | rel=r_associated | relid=0 | w=35
  7. en:methylglucosides -- r_associated #0: 35 / 0.814 -> en:toxicity aspects
    n1=en:methylglucosides | n2=en:toxicity aspects | rel=r_associated | relid=0 | w=35
  8. en:methylglucosides -- r_associated #0: 34 / 0.791 -> en:arbutin
    n1=en:methylglucosides | n2=en:arbutin | rel=r_associated | relid=0 | w=34
  9. en:methylglucosides -- r_associated #0: 34 / 0.791 -> en:esculin
    n1=en:methylglucosides | n2=en:esculin | rel=r_associated | relid=0 | w=34
  10. en:methylglucosides -- r_associated #0: 34 / 0.791 -> en:standards characteristics
    n1=en:methylglucosides | n2=en:standards characteristics | rel=r_associated | relid=0 | w=34
  11. en:methylglucosides -- r_associated #0: 32 / 0.744 -> en:4-(3,4-dihydroxybenzoyloxymethyl)phenyl-o-beta-d-glucopyranoside
    n1=en:methylglucosides | n2=en:4-(3,4-dihydroxybenzoyloxymethyl)phenyl-o-beta-d-glucopyranoside | rel=r_associated | relid=0 | w=32
  12. en:methylglucosides -- r_associated #0: 32 / 0.744 -> en:analysis aspect
    n1=en:methylglucosides | n2=en:analysis aspect | rel=r_associated | relid=0 | w=32
  13. en:methylglucosides -- r_associated #0: 32 / 0.744 -> en:aspects of adverse effects
    n1=en:methylglucosides | n2=en:aspects of adverse effects | rel=r_associated | relid=0 | w=32
  14. en:methylglucosides -- r_associated #0: 32 / 0.744 -> en:canagliflozin
    n1=en:methylglucosides | n2=en:canagliflozin | rel=r_associated | relid=0 | w=32
  15. en:methylglucosides -- r_associated #0: 32 / 0.744 -> en:exposure as collected domain
    n1=en:methylglucosides | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=32
  16. en:methylglucosides -- r_associated #0: 32 / 0.744 -> en:immunology aspects
    n1=en:methylglucosides | n2=en:immunology aspects | rel=r_associated | relid=0 | w=32
  17. en:methylglucosides -- r_associated #0: 32 / 0.744 -> en:methylgalactosides
    n1=en:methylglucosides | n2=en:methylgalactosides | rel=r_associated | relid=0 | w=32
  18. en:methylglucosides -- r_associated #0: 32 / 0.744 -> en:methylmannosides
    n1=en:methylglucosides | n2=en:methylmannosides | rel=r_associated | relid=0 | w=32
  19. en:methylglucosides -- r_associated #0: 32 / 0.744 -> en:thioglucosides
    n1=en:methylglucosides | n2=en:thioglucosides | rel=r_associated | relid=0 | w=32
  20. en:methylglucosides -- r_associated #0: 31 / 0.721 -> en:3-o-methylglucose
    n1=en:methylglucosides | n2=en:3-o-methylglucose | rel=r_associated | relid=0 | w=31
  21. en:methylglucosides -- r_associated #0: 31 / 0.721 -> en:6-o-methylglucose
    n1=en:methylglucosides | n2=en:6-o-methylglucose | rel=r_associated | relid=0 | w=31
  22. en:methylglucosides -- r_associated #0: 31 / 0.721 -> en:cellular secretion
    n1=en:methylglucosides | n2=en:cellular secretion | rel=r_associated | relid=0 | w=31
  23. en:methylglucosides -- r_associated #0: 31 / 0.721 -> en:mechanism of action qualifier
    n1=en:methylglucosides | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=31
  24. en:methylglucosides -- r_associated #0: 31 / 0.721 -> en:metabolic aspects
    n1=en:methylglucosides | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=31
  25. en:methylglucosides -- r_associated #0: 31 / 0.721 -> en:methyl 2-deoxy-2-formamido-d-glucopyranoside
    n1=en:methylglucosides | n2=en:methyl 2-deoxy-2-formamido-d-glucopyranoside | rel=r_associated | relid=0 | w=31
  26. en:methylglucosides -- r_associated #0: 31 / 0.721 -> en:methylglycosides
    n1=en:methylglucosides | n2=en:methylglycosides | rel=r_associated | relid=0 | w=31
  27. en:methylglucosides -- r_associated #0: 30 / 0.698 -> en:2-acetamido-6-azido-4-o-benzyl-2-deoxyglucopyranoside
    n1=en:methylglucosides | n2=en:2-acetamido-6-azido-4-o-benzyl-2-deoxyglucopyranoside | rel=r_associated | relid=0 | w=30
  28. en:methylglucosides -- r_associated #0: 30 / 0.698 -> en:3,6-di-o-methylglucose
    n1=en:methylglucosides | n2=en:3,6-di-o-methylglucose | rel=r_associated | relid=0 | w=30
  29. en:methylglucosides -- r_associated #0: 30 / 0.698 -> en:amygdalin
    n1=en:methylglucosides | n2=en:amygdalin | rel=r_associated | relid=0 | w=30
  30. en:methylglucosides -- r_associated #0: 30 / 0.698 -> en:chemical aspects
    n1=en:methylglucosides | n2=en:chemical aspects | rel=r_associated | relid=0 | w=30
  31. en:methylglucosides -- r_associated #0: 30 / 0.698 -> en:chemical synthesis
    n1=en:methylglucosides | n2=en:chemical synthesis | rel=r_associated | relid=0 | w=30
  32. en:methylglucosides -- r_associated #0: 30 / 0.698 -> en:chloralose
    n1=en:methylglucosides | n2=en:chloralose | rel=r_associated | relid=0 | w=30
  33. en:methylglucosides -- r_associated #0: 30 / 0.698 -> en:in cerebrospinal fluid
    n1=en:methylglucosides | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=30
  34. en:methylglucosides -- r_associated #0: 30 / 0.698 -> en:in urine
    n1=en:methylglucosides | n2=en:in urine | rel=r_associated | relid=0 | w=30
  35. en:methylglucosides -- r_associated #0: 30 / 0.698 -> en:longestin
    n1=en:methylglucosides | n2=en:longestin | rel=r_associated | relid=0 | w=30
  36. en:methylglucosides -- r_associated #0: 30 / 0.698 -> en:methyl 4-o-(4 alpha-glucopyranosyloxy-4-methoxybutyl)-alpha-glucopyranoside
    n1=en:methylglucosides | n2=en:methyl 4-o-(4 alpha-glucopyranosyloxy-4-methoxybutyl)-alpha-glucopyranoside | rel=r_associated | relid=0 | w=30
  37. en:methylglucosides -- r_associated #0: 30 / 0.698 -> en:methylglucoside
    n1=en:methylglucosides | n2=en:methylglucoside | rel=r_associated | relid=0 | w=30
  38. en:methylglucosides -- r_associated #0: 30 / 0.698 -> en:teniposide
    n1=en:methylglucosides | n2=en:teniposide | rel=r_associated | relid=0 | w=30
  39. en:methylglucosides -- r_associated #0: 29 / 0.674 -> en:bioformation
    n1=en:methylglucosides | n2=en:bioformation | rel=r_associated | relid=0 | w=29
  40. en:methylglucosides -- r_associated #0: 29 / 0.674 -> en:contraindications aspect
    n1=en:methylglucosides | n2=en:contraindications aspect | rel=r_associated | relid=0 | w=29
  41. en:methylglucosides -- r_associated #0: 29 / 0.674 -> en:methyl 2-o-methylfucofuranoside
    n1=en:methylglucosides | n2=en:methyl 2-o-methylfucofuranoside | rel=r_associated | relid=0 | w=29
  42. en:methylglucosides -- r_associated #0: 28 / 0.651 -> en:glucosides
    n1=en:methylglucosides | n2=en:glucosides | rel=r_associated | relid=0 | w=28
  43. en:methylglucosides -- r_associated #0: 28 / 0.651 -> en:methyl 4-o-fucopyranosyl-glucopyranoside hemihydrate
    n1=en:methylglucosides | n2=en:methyl 4-o-fucopyranosyl-glucopyranoside hemihydrate | rel=r_associated | relid=0 | w=28
  44. en:methylglucosides -- r_associated #0: 28 / 0.651 -> en:methyl c-gentiobioside
    n1=en:methylglucosides | n2=en:methyl c-gentiobioside | rel=r_associated | relid=0 | w=28
  45. en:methylglucosides -- r_associated #0: 28 / 0.651 -> en:taxonomic
    n1=en:methylglucosides | n2=en:taxonomic | rel=r_associated | relid=0 | w=28
  46. en:methylglucosides -- r_associated #0: 27 / 0.628 -> en:historical aspects qualifier
    n1=en:methylglucosides | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=27
  47. en:methylglucosides -- r_associated #0: 27 / 0.628 -> en:in blood
    n1=en:methylglucosides | n2=en:in blood | rel=r_associated | relid=0 | w=27
  48. en:methylglucosides -- r_associated #0: 27 / 0.628 -> en:methyl 2-deoxy-2-acetamido-d-glucopyranoside
    n1=en:methylglucosides | n2=en:methyl 2-deoxy-2-acetamido-d-glucopyranoside | rel=r_associated | relid=0 | w=27
  49. en:methylglucosides -- r_associated #0: 27 / 0.628 -> en:poisoning aspects
    n1=en:methylglucosides | n2=en:poisoning aspects | rel=r_associated | relid=0 | w=27
  50. en:methylglucosides -- r_associated #0: 27 / 0.628 -> en:sulfoquinovose
    n1=en:methylglucosides | n2=en:sulfoquinovose | rel=r_associated | relid=0 | w=27
  51. en:methylglucosides -- r_associated #0: 26 / 0.605 -> en:agonists
    n1=en:methylglucosides | n2=en:agonists | rel=r_associated | relid=0 | w=26
  52. en:methylglucosides -- r_associated #0: 26 / 0.605 -> en:etoposide
    n1=en:methylglucosides | n2=en:etoposide | rel=r_associated | relid=0 | w=26
  53. en:methylglucosides -- r_associated #0: 26 / 0.605 -> en:therapeutic use - qualifier
    n1=en:methylglucosides | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=26
  54. en:methylglucosides -- r_associated #0: 20 / 0.465 -> arbutine
    n1=en:methylglucosides | n2=arbutine | rel=r_associated | relid=0 | w=20
  55. en:methylglucosides -- r_associated #0: 20 / 0.465 -> téniposide
    n1=en:methylglucosides | n2=téniposide | rel=r_associated | relid=0 | w=20
  56. en:methylglucosides -- r_associated #0: 20 / 0.465 -> ursine
    n1=en:methylglucosides | n2=ursine | rel=r_associated | relid=0 | w=20
≈ 63 relations entrantes

  1. téniposide --- r_associated #0: 87 --> en:methylglucosides
    n1=téniposide | n2=en:methylglucosides | rel=r_associated | relid=0 | w=87
  2. en:teniposide --- r_associated #0: 85 --> en:methylglucosides
    n1=en:teniposide | n2=en:methylglucosides | rel=r_associated | relid=0 | w=85
  3. arbutine --- r_associated #0: 59 --> en:methylglucosides
    n1=arbutine | n2=en:methylglucosides | rel=r_associated | relid=0 | w=59
  4. en:arbutin --- r_associated #0: 55 --> en:methylglucosides
    n1=en:arbutin | n2=en:methylglucosides | rel=r_associated | relid=0 | w=55
  5. ursine --- r_associated #0: 55 --> en:methylglucosides
    n1=ursine | n2=en:methylglucosides | rel=r_associated | relid=0 | w=55
  6. en:methylglycosides --- r_associated #0: 43 --> en:methylglucosides
    n1=en:methylglycosides | n2=en:methylglucosides | rel=r_associated | relid=0 | w=43
  7. en:methyl 2-o-methylfucofuranoside --- r_associated #0: 37 --> en:methylglucosides
    n1=en:methyl 2-o-methylfucofuranoside | n2=en:methylglucosides | rel=r_associated | relid=0 | w=37
  8. en:2-acetamido-6-azido-4-o-benzyl-2-deoxyglucopyranoside --- r_associated #0: 34 --> en:methylglucosides
    n1=en:2-acetamido-6-azido-4-o-benzyl-2-deoxyglucopyranoside | n2=en:methylglucosides | rel=r_associated | relid=0 | w=34
  9. en:bioformation --- r_associated #0: 34 --> en:methylglucosides
    n1=en:bioformation | n2=en:methylglucosides | rel=r_associated | relid=0 | w=34
  10. en:methyl 4-o-fucopyranosyl-glucopyranoside hemihydrate --- r_associated #0: 34 --> en:methylglucosides
    n1=en:methyl 4-o-fucopyranosyl-glucopyranoside hemihydrate | n2=en:methylglucosides | rel=r_associated | relid=0 | w=34
  11. en:methylgalactosides --- r_associated #0: 34 --> en:methylglucosides
    n1=en:methylgalactosides | n2=en:methylglucosides | rel=r_associated | relid=0 | w=34
  12. en:standards characteristics --- r_associated #0: 34 --> en:methylglucosides
    n1=en:standards characteristics | n2=en:methylglucosides | rel=r_associated | relid=0 | w=34
  13. en:3,6-di-o-methylglucose --- r_associated #0: 32 --> en:methylglucosides
    n1=en:3,6-di-o-methylglucose | n2=en:methylglucosides | rel=r_associated | relid=0 | w=32
  14. en:longestin --- r_associated #0: 32 --> en:methylglucosides
    n1=en:longestin | n2=en:methylglucosides | rel=r_associated | relid=0 | w=32
  15. en:methyl 2-deoxy-2-formamido-d-glucopyranoside --- r_associated #0: 32 --> en:methylglucosides
    n1=en:methyl 2-deoxy-2-formamido-d-glucopyranoside | n2=en:methylglucosides | rel=r_associated | relid=0 | w=32
  16. en:methyl 2,3,4,6-tetra-o-methylglucopyranoside --- r_associated #0: 31 --> en:methylglucosides
    n1=en:methyl 2,3,4,6-tetra-o-methylglucopyranoside | n2=en:methylglucosides | rel=r_associated | relid=0 | w=31
  17. en:methyl c-gentiobioside --- r_associated #0: 31 --> en:methylglucosides
    n1=en:methyl c-gentiobioside | n2=en:methylglucosides | rel=r_associated | relid=0 | w=31
  18. en:pharmacokinetic aspects --- r_associated #0: 31 --> en:methylglucosides
    n1=en:pharmacokinetic aspects | n2=en:methylglucosides | rel=r_associated | relid=0 | w=31
  19. en:6-o-methylglucose --- r_associated #0: 30 --> en:methylglucosides
    n1=en:6-o-methylglucose | n2=en:methylglucosides | rel=r_associated | relid=0 | w=30
  20. en:aspects of adverse effects --- r_associated #0: 30 --> en:methylglucosides
    n1=en:aspects of adverse effects | n2=en:methylglucosides | rel=r_associated | relid=0 | w=30
  21. en:aspects of radiation effects --- r_associated #0: 30 --> en:methylglucosides
    n1=en:aspects of radiation effects | n2=en:methylglucosides | rel=r_associated | relid=0 | w=30
  22. en:esculin --- r_associated #0: 30 --> en:methylglucosides
    n1=en:esculin | n2=en:methylglucosides | rel=r_associated | relid=0 | w=30
  23. en:methylmannosides --- r_associated #0: 30 --> en:methylglucosides
    n1=en:methylmannosides | n2=en:methylglucosides | rel=r_associated | relid=0 | w=30
  24. en:taxonomic --- r_associated #0: 30 --> en:methylglucosides
    n1=en:taxonomic | n2=en:methylglucosides | rel=r_associated | relid=0 | w=30
  25. en:4-(3,4-dihydroxybenzoyloxymethyl)phenyl-o-beta-d-glucopyranoside --- r_associated #0: 29 --> en:methylglucosides
    n1=en:4-(3,4-dihydroxybenzoyloxymethyl)phenyl-o-beta-d-glucopyranoside | n2=en:methylglucosides | rel=r_associated | relid=0 | w=29
  26. en:glucosides --- r_associated #0: 29 --> en:methylglucosides
    n1=en:glucosides | n2=en:methylglucosides | rel=r_associated | relid=0 | w=29
  27. en:immunology aspects --- r_associated #0: 29 --> en:methylglucosides
    n1=en:immunology aspects | n2=en:methylglucosides | rel=r_associated | relid=0 | w=29
  28. en:iridoid glucosides --- r_associated #0: 29 --> en:methylglucosides
    n1=en:iridoid glucosides | n2=en:methylglucosides | rel=r_associated | relid=0 | w=29
  29. en:metabolic aspects --- r_associated #0: 29 --> en:methylglucosides
    n1=en:metabolic aspects | n2=en:methylglucosides | rel=r_associated | relid=0 | w=29
  30. en:methyl 2-deoxy-2-acetamido-d-glucopyranoside --- r_associated #0: 29 --> en:methylglucosides
    n1=en:methyl 2-deoxy-2-acetamido-d-glucopyranoside | n2=en:methylglucosides | rel=r_associated | relid=0 | w=29
  31. en:methyl 4-thio-alpha-maltoside --- r_associated #0: 29 --> en:methylglucosides
    n1=en:methyl 4-thio-alpha-maltoside | n2=en:methylglucosides | rel=r_associated | relid=0 | w=29
  32. en:methylglucoside --- r_associated #0: 29 --> en:methylglucosides
    n1=en:methylglucoside | n2=en:methylglucosides | rel=r_associated | relid=0 | w=29
  33. en:therapeutic use - qualifier --- r_associated #0: 29 --> en:methylglucosides
    n1=en:therapeutic use - qualifier | n2=en:methylglucosides | rel=r_associated | relid=0 | w=29
  34. en:agonists --- r_associated #0: 28 --> en:methylglucosides
    n1=en:agonists | n2=en:methylglucosides | rel=r_associated | relid=0 | w=28
  35. en:amygdalin --- r_associated #0: 28 --> en:methylglucosides
    n1=en:amygdalin | n2=en:methylglucosides | rel=r_associated | relid=0 | w=28
  36. en:contraindications aspect --- r_associated #0: 28 --> en:methylglucosides
    n1=en:contraindications aspect | n2=en:methylglucosides | rel=r_associated | relid=0 | w=28
  37. en:mechanism of action qualifier --- r_associated #0: 28 --> en:methylglucosides
    n1=en:mechanism of action qualifier | n2=en:methylglucosides | rel=r_associated | relid=0 | w=28
  38. en:methyl 4-o-(4 alpha-glucopyranosyloxy-4-methoxybutyl)-alpha-glucopyranoside --- r_associated #0: 28 --> en:methylglucosides
    n1=en:methyl 4-o-(4 alpha-glucopyranosyloxy-4-methoxybutyl)-alpha-glucopyranoside | n2=en:methylglucosides | rel=r_associated | relid=0 | w=28
  39. en:3-o-methylglucose --- r_associated #0: 27 --> en:methylglucosides
    n1=en:3-o-methylglucose | n2=en:methylglucosides | rel=r_associated | relid=0 | w=27
  40. en:cellular secretion --- r_associated #0: 27 --> en:methylglucosides
    n1=en:cellular secretion | n2=en:methylglucosides | rel=r_associated | relid=0 | w=27
  41. en:poisoning aspects --- r_associated #0: 27 --> en:methylglucosides
    n1=en:poisoning aspects | n2=en:methylglucosides | rel=r_associated | relid=0 | w=27
  42. en:thioglucosides --- r_associated #0: 27 --> en:methylglucosides
    n1=en:thioglucosides | n2=en:methylglucosides | rel=r_associated | relid=0 | w=27
  43. en:toxicity aspects --- r_associated #0: 26 --> en:methylglucosides
    n1=en:toxicity aspects | n2=en:methylglucosides | rel=r_associated | relid=0 | w=26
  44. en:analysis aspect --- r_associated #0: 24 --> en:methylglucosides
    n1=en:analysis aspect | n2=en:methylglucosides | rel=r_associated | relid=0 | w=24
  45. en:chemical aspects --- r_associated #0: 24 --> en:methylglucosides
    n1=en:chemical aspects | n2=en:methylglucosides | rel=r_associated | relid=0 | w=24
  46. en:chemical synthesis --- r_associated #0: 24 --> en:methylglucosides
    n1=en:chemical synthesis | n2=en:methylglucosides | rel=r_associated | relid=0 | w=24
  47. en:etoposide --- r_associated #0: 24 --> en:methylglucosides
    n1=en:etoposide | n2=en:methylglucosides | rel=r_associated | relid=0 | w=24
  48. en:in blood --- r_associated #0: 24 --> en:methylglucosides
    n1=en:in blood | n2=en:methylglucosides | rel=r_associated | relid=0 | w=24
  49. en:in cerebrospinal fluid --- r_associated #0: 24 --> en:methylglucosides
    n1=en:in cerebrospinal fluid | n2=en:methylglucosides | rel=r_associated | relid=0 | w=24
  50. en:canagliflozin --- r_associated #0: 23 --> en:methylglucosides
    n1=en:canagliflozin | n2=en:methylglucosides | rel=r_associated | relid=0 | w=23
  51. en:chloralose --- r_associated #0: 23 --> en:methylglucosides
    n1=en:chloralose | n2=en:methylglucosides | rel=r_associated | relid=0 | w=23
  52. en:exposure as collected domain --- r_associated #0: 23 --> en:methylglucosides
    n1=en:exposure as collected domain | n2=en:methylglucosides | rel=r_associated | relid=0 | w=23
  53. en:genetic aspects --- r_associated #0: 23 --> en:methylglucosides
    n1=en:genetic aspects | n2=en:methylglucosides | rel=r_associated | relid=0 | w=23
  54. en:in urine --- r_associated #0: 23 --> en:methylglucosides
    n1=en:in urine | n2=en:methylglucosides | rel=r_associated | relid=0 | w=23
  55. en:historical aspects qualifier --- r_associated #0: 21 --> en:methylglucosides
    n1=en:historical aspects qualifier | n2=en:methylglucosides | rel=r_associated | relid=0 | w=21
  56. en:sulfoquinovose --- r_associated #0: 21 --> en:methylglucosides
    n1=en:sulfoquinovose | n2=en:methylglucosides | rel=r_associated | relid=0 | w=21
  57. amygdaline --- r_associated #0: 10 --> en:methylglucosides
    n1=amygdaline | n2=en:methylglucosides | rel=r_associated | relid=0 | w=10
  58. esculine --- r_associated #0: 10 --> en:methylglucosides
    n1=esculine | n2=en:methylglucosides | rel=r_associated | relid=0 | w=10
  59. glucosides --- r_associated #0: 10 --> en:methylglucosides
    n1=glucosides | n2=en:methylglucosides | rel=r_associated | relid=0 | w=10
  60. sulfoquinovose --- r_associated #0: 10 --> en:methylglucosides
    n1=sulfoquinovose | n2=en:methylglucosides | rel=r_associated | relid=0 | w=10
  61. taxinomique --- r_associated #0: 10 --> en:methylglucosides
    n1=taxinomique | n2=en:methylglucosides | rel=r_associated | relid=0 | w=10
  62. étoposide --- r_associated #0: 10 --> en:methylglucosides
    n1=étoposide | n2=en:methylglucosides | rel=r_associated | relid=0 | w=10
  63. Arbutine --- r_associated #0: 5 --> en:methylglucosides
    n1=Arbutine | n2=en:methylglucosides | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr